Screener
Climb Bio, Inc. CLYM Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $860 | $2,269 |
| Accrued expenses and other current liabilities | 2,948 | 4,459 |
| Operating lease liabilities | 263 | 256 |
| Total current liabilities | 4,071 | 6,984 |
| Operating lease liabilities, net of current portion | 216 | 285 |
| Total liabilities | 4,287 | 7,269 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity: |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s total current liabilities?
- Climb Bio, Inc. (CLYM) reported total current liabilities of $4.07M in Q1 2026.
- How has Climb Bio, Inc.'s total current liabilities changed year-over-year?
- Climb Bio, Inc.'s total current liabilities decreased by 42.1% year-over-year, from $7.04M to $4.07M.
- What is the long-term trend for Climb Bio, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s total current liabilities has grown at a 17.9% compound annual growth rate (CAGR), from $3.06M to $6.98M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Climb Bio, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude